Optimization of an in Silico Cardiac Cell Model for Proarrhythmia Risk Assessment

Frontiers in Physiology - Switzerland
doi 10.3389/fphys.2017.00616
Full Text
Abstract

Available in full text

Categories
Physiology
Date
Authors
Publisher

Frontiers Media SA

Related search

TCPRO: An In-Silico Risk Assessment Tool for Biotherapeutic Protein Immunogenicity

Biophysical Journal
Biophysics
2019English

Comparative Assessment of Prurifloxacin, Sparfloxacin, Gatifloxacin and Levofloxacin in the Rabbit Model of Proarrhythmia

Journal of Toxicological Sciences
MedicineToxicology
2004English

An Improved Stochastic Model for Cybersecurity Risk Assessment

Computer and Information Science
2019English

Incorporating Risk in an Optimization Model of Reliability Engineering

International Journal of Economic Behavior and Organization
2015English

An Individualized Risk Assessment of Sudden Cardiac Death in Dilation Cardiomyopathy Patients

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2016English

Guidelines for Pre-Operative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-Cardiac Surgery

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2010English

Bayesian Spatial-Temporal Model for Cardiac Congenital Anomalies and Ambient Air Pollution Risk Assessment

Environmetrics
Ecological ModelingStatisticsProbability
2012English

Risk Assessment of Chemicals in Food and in Silico Toxicology (Short Overview).

Inter Collegas
2017English

An in Silico Study of Energy Metabolism in Cardiac Excitation-Contraction Coupling

The Japanese Journal of Physiology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy